CAV1 and cancer: Hereby, the CaV1 inhibitor BK10040 was reported to reduce proliferation and induce apoptosis in cancer cells such as A459 (lung adenocarcinoma) and MiaPaCa2 (pancreatic cancer cells) cell lines.